The study revealed a number of regulatory genes related to hepatic lipid metabolism of NAFLD, and demonstrated that MAP3K4 played a pivotal role in the hepatic lipogenesis of NAFLD. Here, MAP3K4 is linked to metabolic dysfunction-associated steatotic liver disease.